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Abstract Four chromosomal loci (PARK2, PARK6, PARK7,
and PARK9) associated with autosomal recessive, early onset
parkinsonism are known. We mapped the PARK7 locus to
chromosome 1p36 in a large family from a genetically iso-
lated population in the Netherlands, and confirmed this link-
age in an Italian family. By positional cloning within the
refined PARK7 critical region we recently identified muta-
tions in the DJ-1 gene in the two PARK7-linked families.
The function of DJ-1 remains largely unknown, but evidence
from genetic studies on the yeast DJ-1 homologue, and bio-
chemical studies in murine and human cell lines, suggests a
role for DJ-1 as an antioxidant and/or a molecular chaperone.
Elucidating the role of DJ-1 will lead to a better understand-
ing of the pathogenesis of DJ-1-related and common forms
of Parkinson’s disease.
By genome-wide scan and homozygosity mapping, we iden-
tified the PARK7 locus in a large consanguineous family with
four affected individuals, belonging to a genetically isolated
population in the south west of the Netherlands [1]. Linkage
to the same region was later confirmed in a consanguineous
pedigree from central Italy with three affected members [2].
The phenotype in both families is characterized by parkin-
sonism of early onset (ranging from age 27 to 40 years),
good levodopa response, and slow progression. Behavioral
and psychic disturbances and dystonic features (including
blepharospasm) are also present, and a positron emission
tomography study in the Dutch family showed dopaminergic
presynaptic dysfunctions [1–3].
Fine mapping studies and a positional cloning strategy
led us to the identification of homozygous mutations in the
DJ-1 gene showing complete cosegregation with the disease
haplotype and absence from large numbers of control chro-
mosomes: a ~14-kb deletion removing a large part of the DJ-
1 coding region in the Dutch family and a missense mutation
(Leucine166Proline, L166P) in the Italian family (Fig. 1) [4].
The expression of the DJ-1 gene is abolished by the
homozygous deletion in the patients of the Dutch family,
indicating that the loss of DJ-1 function is pathogenic. The
L166P mutation is also likely to severely affect the function
of DJ-1 because: (1) it replaces a highly conserved residue in
the DJ-1 protein, (2) it destabilizes the carboxy-terminal a-
helix of the DJ-1 protein as predicted by structural models,
and (3) it dramatically changes the subcellular localization of
the DJ-1 protein in transfection experiments [4].
The human DJ-1 is organized in eight exons distributed
over 24 kb. The first two exons are non-coding and alterna-
tively spliced in the mRNA. DJ-1 is ubiquitously and highly
expressed in the brain areas and extra-cerebral tissues. The
human DJ-1 protein has 189 amino acids and belongs to the
ThiJ/PfpI family. The exact function of the DJ-1 protein is
unknown, but previous reports suggested an involvement in
multiple cellular processes, including oncogenesis, regula-
tion of RNA-binding protein complexes, sperm maturation
and fertilization in rodents, and regulation of androgen
receptor-mediated transcriptional activity [4]. Interestingly,
studies in murine and human cell lines showed that the DJ-1
protein is converted into a more-acidic variant in response to
oxidative stress, suggesting a role as an antioxidant [5].
Moreover, the yeast DJ-1 homologue is transcribed during
the oxidative stress response and during the response to pro-
tein misfolding (which in turn is associated with oxidative
stress), raising the question of whether DJ-1 also plays a role
as a molecular chaperone [6, 7]. DJ-1 might therefore be
involved in the cellular response to stress at multiple levels.
It might directly react to stress signals by chemical shifts
and/or change in multimerization state; it might also modu-
late the gene expression of the stress response at transcrip-
tional and/or post-transcriptional levels [4]. Although an
involvement of human DJ-1 in the oxidative stress response,
or in the response to protein misfolding, remains to be
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Fig. 1 Genomic structure of the DJ-1 gene showing the two muta-
tions identified [4]. Black and grey boxes indicate non-coding and
coding exonic sequences, respectively
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proven, the proposed model is intriguing in the light of the
oxidative stress and protein misfolding documented in the
brains of patients with Parkinson’s disease (PD).
Mutational analyses in large series of patients with early
onset PD are currently in progress to evaluate the frequency
of DJ-1 mutations, pinpoint functionally important domains
in the DJ-1 protein, and allow accurate genotype-phenotype
correlation studies. Although brain material from patients
with DJ-1-related forms is not currently available, the pres-
ence of the DJ-1 protein is being investigated in brains from
patients with Lewy body disease, as well as other neurode-
generative diseases. These studies might provide clues on the
involvement of DJ-1 in common forms of neurodegenera-
tion. Lastly, functional studies are in progress to elucidate
further the role of DJ-1, identify its interacting partners, and
explore possible relationships with the proteins encoded by
the other genes firmly implicated in PD: α-synuclein and
parkin [8]. Understanding the role of DJ-1 in the brain and
the DJ-1-related disease might shed light on the mechanisms
of brain maintenance and the pathogenesis of classical PD.
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